CH573936A5 - - Google Patents

Info

Publication number
CH573936A5
CH573936A5 CH1134872A CH1134872A CH573936A5 CH 573936 A5 CH573936 A5 CH 573936A5 CH 1134872 A CH1134872 A CH 1134872A CH 1134872 A CH1134872 A CH 1134872A CH 573936 A5 CH573936 A5 CH 573936A5
Authority
CH
Switzerland
Application number
CH1134872A
Inventor
V Zikan
M Semonsky
K Rezabek
M Seda
M Auskova
Original Assignee
Spofa Vereinigte Pharma Werke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CS568971A external-priority patent/CS152153B1/cs
Priority claimed from CS570971A external-priority patent/CS156178B1/cs
Application filed by Spofa Vereinigte Pharma Werke filed Critical Spofa Vereinigte Pharma Werke
Publication of CH573936A5 publication Critical patent/CH573936A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CH1134872A 1971-08-05 1972-07-31 CH573936A5 (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CS568971A CS152153B1 (en:Method) 1971-08-05 1971-08-05
CS570971A CS156178B1 (en:Method) 1971-08-05 1971-08-05

Publications (1)

Publication Number Publication Date
CH573936A5 true CH573936A5 (en:Method) 1976-03-31

Family

ID=25746228

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1604375A CH573937A5 (en:Method) 1971-08-05 1972-07-31
CH1134872A CH573936A5 (en:Method) 1971-08-05 1972-07-31

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH1604375A CH573937A5 (en:Method) 1971-08-05 1972-07-31

Country Status (12)

Country Link
US (1) US3953454A (en:Method)
JP (1) JPS5247480B2 (en:Method)
BE (1) BE787036A (en:Method)
CA (1) CA976958A (en:Method)
CH (2) CH573937A5 (en:Method)
DE (1) DE2238540C3 (en:Method)
DK (1) DK140500B (en:Method)
FI (1) FI53127C (en:Method)
FR (1) FR2150746B1 (en:Method)
GB (1) GB1358358A (en:Method)
NL (1) NL174550C (en:Method)
SE (1) SE374111B (en:Method)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS522798A (en) * 1975-06-24 1977-01-10 Fuji Electric Co Ltd Control system for automatic sales machine
JPS522799A (en) * 1975-06-24 1977-01-10 Fuji Electric Co Ltd Control system for automatic sales machine
US4096266A (en) * 1976-04-06 1978-06-20 Hzi Research Center Lisuride in alcoholism
DE3063869D1 (en) * 1979-06-13 1983-07-28 Schering Ag (ergolin-yl)-n', n'-diethyl urea derivatives, their preparation and pharmaceutical compositions containing them
JPS5660173U (en:Method) * 1979-10-09 1981-05-22
DE3001752A1 (de) * 1980-01-16 1981-07-30 Schering Ag Berlin Und Bergkamen, 1000 Berlin Verfahren zur herstellung von 8(alpha)-substituierten 6-methylergolinen
DE3101535A1 (de) * 1981-01-14 1982-08-12 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue (2-halogen-ergolinyl)-n'.n'-diethyl-harnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE3129714A1 (de) * 1981-07-23 1983-02-10 Schering Ag, 1000 Berlin Und 4619 Bergkamen Anti-psychotikum
DE3151912A1 (de) * 1981-12-23 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE3216869A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Synergistische kombination mit zytostatischer wirkung
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
DE3309493A1 (de) * 1983-03-14 1984-09-20 Schering AG, 1000 Berlin und 4709 Bergkamen Neue ergolin-derivate, verfahren zu ihrer herstellung sowie verwendung als arzneimittel
DE3410218A1 (de) * 1984-03-16 1985-09-19 Schering AG, Berlin und Bergkamen, 1000 Berlin Tergurid als antihypertensivum
DE3413660A1 (de) * 1984-04-09 1985-10-17 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von 2-(trialkyl-silyl)-ergolinderivaten
EP0160842B1 (de) * 1984-04-09 1994-06-22 Schering Aktiengesellschaft 2-substituierte Ergolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE3522894A1 (de) * 1985-06-24 1987-01-02 Schering Ag Verwendung von tergurid als geriatrikum
DE3533675A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-brom-ergolinderivate
DE3535930A1 (de) * 1985-10-04 1987-04-09 Schering Ag Neue 2-substituierte ergolinderivate
US5252335A (en) * 1989-07-12 1993-10-12 Cygnus Therapeutic Systems Transdermal administration of lisuride
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10066158B4 (de) 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US9585885B2 (en) 2012-12-10 2017-03-07 Kissei Pharmaceutical Co., Ltd. Substituted pyrido[2,3-g]quinazolines as dopamine D2 receptor agonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3251846A (en) * 1966-05-17 G-dimethyosoergolenyl-b
US3270020A (en) * 1966-08-30 Dihydro ergocornine
CH344731A (de) * 1956-05-18 1960-02-29 Sandoz Ag Verfahren zur Herstellung von neuen, am Indolstickstoff alkylierten Derivaten der Lysergsäure-Reihe
GB1053507A (en:Method) * 1964-04-14
US3681497A (en) * 1966-06-07 1972-08-01 Spofa Vereinigte Pharma Werke Therapeutic methods of employing hydrogen maleate salt of n-(d-6-methyl-8-isoergolenyl)-n{40 ,n{40 -diethyl-carbamide

Also Published As

Publication number Publication date
FR2150746A1 (en:Method) 1973-04-13
CA976958A (en) 1975-10-28
DK140500B (da) 1979-09-17
BE787036A (fr) 1972-12-01
SE374111B (en:Method) 1975-02-24
DK140500C (en:Method) 1980-02-11
NL174550C (nl) 1984-07-02
JPS5247480B2 (en:Method) 1977-12-02
GB1358358A (en) 1974-07-03
US3953454A (en) 1976-04-27
CH573937A5 (en:Method) 1976-03-31
NL7210812A (en:Method) 1973-02-07
FI53127C (en:Method) 1978-02-10
DE2238540B2 (de) 1977-09-29
DE2238540A1 (de) 1973-02-22
DE2238540C3 (de) 1978-05-24
JPS4826799A (en:Method) 1973-04-09
NL174550B (nl) 1984-02-01
FR2150746B1 (en:Method) 1976-07-02
FI53127B (en:Method) 1977-10-31

Similar Documents

Publication Publication Date Title
CS167989B2 (en:Method)
DK140500C (en:Method)
FR2156396A1 (en:Method)
CS168587B2 (en:Method)
CS173728B1 (en:Method)
DE2106256C3 (en:Method)
FR2142133A5 (en:Method)
FR2104628B3 (en:Method)
CS161242B1 (en:Method)
CS159913B1 (en:Method)
CS163424B1 (en:Method)
CS155923B1 (en:Method)
CS158965B1 (en:Method)
CS157854B1 (en:Method)
CS157775B1 (en:Method)
CS156652B1 (en:Method)
CS148205B1 (en:Method)
BG18487A1 (en:Method)
DD106379A5 (en:Method)
BG17388A1 (en:Method)
BG17086A1 (en:Method)
BG16979A1 (en:Method)
CH341672A4 (en:Method)
CH461371A4 (en:Method)
CH503771A4 (en:Method)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased